Will cases of leprosy reaction increase with COVID-19 infection?

In the T1R, the type 1 helper (Th1) response predominates in lesions and the serum of patients with high levels of cytokines tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), interleukin-17 (IL-17), and C-X-C motif chemokine 10 (CXCL10) [9]. The anti-inflammatory and immunosuppressive e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS neglected tropical diseases 2020-07, Vol.14 (7), p.e0008460
Hauptverfasser:	Antunes, Douglas Eulálio, Goulart, Isabela Maria Bernardes, Goulart, Luiz Ricardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Alcohols Betacoronavirus Biology and Life Sciences Care and treatment Chemokines Clinical trials Coronavirus Infections - epidemiology Coronaviruses Cough COVID-19 CXCL10 protein Cytokines Development and progression Doctors Drug dosages Elbow Glucocorticoids Health services Humans Incidence Infections Inflammation Interferon Interleukin Interleukin 17 Interleukins Leprostatic Agents - adverse effects Leprostatic Agents - therapeutic use Leprosy Leprosy - drug therapy Leprosy - epidemiology Lesions Lymphocytes T Masks Medical research Medicine and Health Sciences Methylprednisolone Necroses Necrosis Neoplasms Pandemics Patients Physicians Pneumonia, Viral - epidemiology Preventive medicine Risk factors SARS-CoV-2 Serum Severe acute respiratory syndrome coronavirus 2 Thalidomide Tropical diseases Tumor necrosis factor-α Tumours Viewpoints γ-Interferon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!